Loading clinical trials...
Loading clinical trials...
Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial
Conditions
Interventions
Psilocybin
Locations
1
United States
Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research Center
Columbus, Ohio, United States
Start Date
January 1, 2023
Primary Completion Date
December 31, 2025
Completion Date
July 31, 2026
Last Updated
March 4, 2026
NCT06956781
NCT07010757
NCT07462312
NCT06804525
NCT07351305
NCT07447089
Lead Sponsor
Ohio State University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions